Braveheart Bio Inc (BRVE)

Currency in USD
19.62
-0.88(-4.29%)
Closed·
19.620.00(0.00%)
·
BRVE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.1820.41
52 wk Range
16.7032.00
Key Statistics
Prev. Close
20.5
Open
20.41
Day's Range
19.18-20.41
52 wk Range
16.7-32
Volume
536.61K
Average Volume (3m)
440.17K
1-Year Change
-
Book Value / Share
6.10
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BRVE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
45.50
Upside
+131.91%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Braveheart Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 45.50
(+131.91% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Stifel
Buy45.00+129.36%-MaintainNov 11, 2026
Stifel
Buy45.00+129.36%-MaintainOct 01, 2026
Goldman Sachs
Buy48.00+144.65%-MaintainSep 14, 2026
Stifel
Buy45.00+129.36%45.00MaintainSep 09, 2026

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
-0.51 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BRVE Income Statement

Compare BRVE to Peers and Sector

Metrics to compare
BRVE
Peers
Sector
Relationship
P/E Ratio
−25.7x−0.5x−0.2x
PEG Ratio
-−0.150.00
Price/Book
3.2x−0.1x2.6x
Price / LTM Sales
-1.4x2.8x
Upside (Analyst Target)
131.9%121.3%65.0%
Fair Value Upside
Unlock22.1%9.6%Unlock

Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. It develops and offers BHB-1893 and HRS-1893, an oral small-molecule cardiac myosin inhibitor (CMI) for the treatment of obstructive HCM and non-obstructive HCM. The company was incorporated in 2024 and is headquartered in San Francisco, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
7.80M9.55%153.01M
Other Institutional Investors
99.85M90.45%1.96B
Public Companies & Retail Investors
0.000.00%0.00
Total
107.65M100.00%2.11B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Forbion Capital Partners B.V.26.74%21,826,024428,227
OrbiMed Advisors LLC14.91%12,175,159238,877

People Also Watch

16.36
SCTX
-3.71%
28.43
PBLS
+2.67%
15.13
ATTO
-4.30%
16.92
APMD
+1.74%

FAQ

What Is the Braveheart Bio (BRVE) Stock Price Today?

The Braveheart Bio stock price today is 19.62 USD.

What Stock Exchange Does Braveheart Bio Trade On?

Braveheart Bio is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Braveheart Bio?

The stock symbol for Braveheart Bio is "BRVE."

What Is the Braveheart Bio Market Cap?

As of today, Braveheart Bio market cap is 1.67B USD.

What Is Braveheart Bio's Earnings Per Share (TTM)?

The Braveheart Bio EPS (TTM) is -3.39.

From a Technical Analysis Perspective, Is BRVE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Braveheart Bio Stock Split?

Braveheart Bio has split 0 times.

How Many Employees Does Braveheart Bio Have?

Braveheart Bio has 49 employees.

What is the current trading status of Braveheart Bio (BRVE)?

As of Nov 14, 2026, Braveheart Bio (BRVE) is trading at a price of 19.62 USD, with a previous close of 20.50 USD. The stock has fluctuated within a day range of 19.18 USD to 20.41 USD, while its 52-week range spans from 16.70 USD to 32.00 USD.

What Is Braveheart Bio (BRVE) Price Target According to Analysts?

The average 12-month price target for Braveheart Bio is 45.50 USD, with a high estimate of 49 USD and a low estimate of 40 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +131.91% Upside potential.

What Is the BRVE Premarket Price?

BRVE's last pre-market stock price is 19.98 USD. The pre-market share volume is 20.00, and the stock has decreased by -0.52, or -2.54%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.